Pharmacotherapeutic Strategies to Prevent Relapse in Schizophrenia / 신경정신의학
Journal of Korean Neuropsychiatric Association
;
: 225-229, 2018.
Artículo
en Coreano
| WPRIM
| ID: wpr-716140
ABSTRACT
Successful treatment is very high in patients with first episode schizophrenia (FES). On the other hand, the problem is a frequent relapse often caused by non-compliance. The non-compliance rate in patients with FES is 40–60% within 1 year. The causes of non-compliance are diverse, such as poor insight, drug side effects, attitude of caregiver, social stigma, etc. Clinicians should be able to provide appropriate psychosocial intervention and long acting injectable antipsychotics (LAI) to overcome non-compliance. Recently, there is solid and accumulating evidence demonstrating superiority of LAI over oral medication in terms of reducing relapse or rehospitalization. In particular, a substantial portion (approximately 30–50%) of patients and caregivers prefer LAI to oral medication. Shared decision-making is the process that clinicians and patients/caregiver should go through in order to obtain the full benefits from LAI.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Recurrencia
/
Esquizofrenia
/
Antipsicóticos
/
Cuidadores
/
Adaptabilidad
/
Toma de Decisiones
/
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
/
Estigma Social
/
Mano
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Coreano
Revista:
Journal of Korean Neuropsychiatric Association
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS